Therapeutic vaccine with irradiated fibroblasts from patients' skin that have been engineered to produce interleukin-2: Began a Phase I trial in 12 patients to

The Immune Response Corp. (IMNR)

Read the full 54 word article

How to gain access

Continue reading with a
two-week free trial.